Infants receiving nirsevimab fare better against RSV compared to those with maternal vaccination

Respiratory syncytial virus (RSV) is a common virus that affects the nose, throat, and lungs. For most healthy adults and children, it causes only mild, cold-like symptoms and goes away on its own. Infants under 6 months of age, however, can…

Continue Reading

News Source: medicalxpress.com